Former Pres. Pinoy witnessed  DOH Sec. Garin administer 1st dengvaxia shot to Zambo kid, photo from necitizen.co
Over 700,000 Filipino children were vaccinated with what turned out to be a dangerous solution, according to the blog site Thinking Pinoy.

According to the blog's Facebook page, the drug was Sanofi Pasteur's Dengvaxia, and former President Benigno Aquino III during his term ordered then Health SecretaryJanette Garin to administer the drug for the Dengue Vaccine School-Based Immunization to a nine-year old grade school pupils in 2016.



"The activity forms part of the DOH’s National Immunization Program to provide free dengue vaccine to indigent public school students in three regions in the country with the highest dengue incidence, including the National Capital Region (NCR), Regions III (Central Luzon) and IV-A (CALABARZON)," according to an RTVM report.

The government then purchased 3.5 billion worth of Sanofi Pasteur's Dengvaxia, despite the fact that the World Health Organization Philippines guidelines have yet to be issued.

The Aquino Administration ordered the vaccination of 1,000,000 school children.

This was pulled through despite the objections of several senior government health officials, and definitive information that the vaccine is not yet definitively proven to be safe for administration to seronegative children aged 9 years and above.



"Seronegative" means the absence of a virus in a subject's bloodstream.

After the drug has already been administered to over 700,000 school children, the World Health Organization declared it to be dangerous/

Apparently, children who were vaccinated with Dengvaxia will suffer worse cases of dengue compared to seronegative children who never got vaccinated.
Source: The Thinking Pinoy


Love this article? Please like our Facebook page below and Share this article to your friends!

LOOK: PNoy watches ex-DOH Sec Garin inject Dengvaxia vaccine to Zambo Kid LOOK: PNoy watches ex-DOH Sec Garin inject Dengvaxia vaccine to Zambo Kid Reviewed by FN Correspondent on Sunday, December 03, 2017 Rating: 5

No comments:

Share your thoughts here...

Powered by Blogger.